openPR Logo
Press release

Mastitis Market Size, Share, Segment Analysis and Forecasts to 2027| Bayer AG , Oncothyreon Inc , OncoGenex , Apthera Inc., Zoetis Inc., Boehringer Ingelheim GmbH

01-11-2022 12:01 PM CET | Health & Medicine

Press release from: Market Research Future (MRFR)

Mastitis Market Size, Share, Segment Analysis and Forecasts

According to a detailed report provided by Market Research Future (MRFR), the global mastitis market is projected to reach a valuation of USD 18,338 million by 2023 contributing to the market growth at nearly 15.07% CAGR during the forecast period of 2017 of 2023.

Mastitis is a form of infection that occurs is the tissue of one or both mammary glands present inside the breast and causes inflammation, swelling, and tenderness of the breast tissues. It is a common occurrence caused due to a blocked duct among breastfeeding women. There is a high chance of women suffering from breast cancer to contract mastitis.

Multiple factors are expected to influence the market. The World Cancer Research Fund refers to breast cancer as the most common type of cancer in women globally, and second-most common cancer overall. In 2018, The WCRF also registered more than 2 million new cases of breast cancer.

Get Sample Copy of “Mastitis Market” @ https://www.marketresearchfuture.com/sample_request/5379

Key Players

Apthera Inc. (U.K.)

Astellas Pharma Inc. (Japan)

Bayer AG (Germany)

BioNumerik Pharmaceuticals Inc. (U.S.)

Boehringer Ingelheim GmbH (Germany)

Hoffmann-La Roche Ltd. (Switzerland)
Merck Co & Inc. (U.S.)

Novartis AG (Switzerland)

Oncogenex (U.S.)

Oncothyreon Inc. (U.S.)

Pfizer Inc. (U.S.)

Sanofi S.A. (France)

Zoetis Inc. (U.S.)

Segmental Analysis

The Global Mastitis Market is segmented based on type, treatment, end-user, and region.

Based on type, the market has been segmented into human mastitis and bovine mastitis. The human mastitis segment is further segmented into non-infectious mastitis and infectious mastitis. The bovine mastitis is further segmented into contagious mastitis, environmental mastitis, and opportunist mastitis.

Based on treatment, the mastitis market has been segmented into antibiotics, pain relievers, surgery, vaccines, and others.

Based on end-user, the mastitis market has been segmented into hospitals and clinics, veterinary centers, and others. The hospital and clinics segment is expected to account for the largest market share over the forecast period, followed by the veterinary centers segment.

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/mastitis-market-5379

Regional Analysis:

North America dominates the Mastitis market globally; the growth is largely supported by the US. Market is driven by the increasing prevalence of the disease fuelled by the consequences of the wrong lifestyle. Factors such as technological advances coupled with the increasing healthcare expenditure support the market growth. Europe region is the second largest market for the Mastitis market. Asia Pacific is emerging as the fastest growing market owing to the rising medical tourism market in the region.
Browse Related Reports @
https://www.marketresearchfuture.com/reports/healthcare-bpo-market-1335
https://www.marketresearchfuture.com/reports/body-contouring-market-1343
https://www.marketresearchfuture.com/reports/neuropathic-pain-market-1390

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Mastitis Market Size, Share, Segment Analysis and Forecasts to 2027| Bayer AG , Oncothyreon Inc , OncoGenex , Apthera Inc., Zoetis Inc., Boehringer Ingelheim GmbH here

News-ID: 2523490 • Views:

More Releases from Market Research Future (MRFR)

Tofu Market to Reach USD 2.7 Billion by 2032 at 9.01% CAGR Driven by Rising Plant-Based Food Preferences
Tofu Market to Reach USD 2.7 Billion by 2032 at 9.01% CAGR Driven by Rising Plan …
The global tofu market is poised for substantial growth over the next decade, projected to reach an impressive valuation of USD 2.7 billion by 2032. This expansion reflects a compound annual growth rate (CAGR) of 9.01% from 2024 to 2032, fueled by a surge in consumer demand for plant-based foods and an evolving global food culture. As more consumers seek healthier and sustainable alternatives to animal-based protein sources, tofu has
Plant-Based Food Ingredients Market to Hit USD 40.2 Billion by 2035 at 7.96% CAGR Driven by Health & Sustainability
Plant-Based Food Ingredients Market to Hit USD 40.2 Billion by 2035 at 7.96% CAG …
The global plant-based food ingredients market is witnessing remarkable growth, propelled by an increasing shift in consumer preferences toward healthier and more sustainable food options. According to recent market research by Market Research Future, the market was valued at USD 16.03 billion in 2023 and is projected to reach an impressive USD 40.2 billion by 2035. This growth trajectory is expected to continue at a compound annual growth rate (CAGR)
Semolina Market to Reach USD 2.57 Billion by 2032 at 2.31% CAGR, Driven by Health Trends & Flour Mill Growth
Semolina Market to Reach USD 2.57 Billion by 2032 at 2.31% CAGR, Driven by Healt …
The global semolina market is poised for steady growth over the coming decade, with its valuation expected to reach USD 2.57 billion by 2032. According to the latest Market Research Future analysis, the market was valued at USD 2.12 billion in 2023 and is projected to expand from USD 2.14 billion in 2024 to USD 2.57 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 2.31% during the
Ginger Extract Market to Reach USD 2.18 Billion by 2034 at 5.4% CAGR Driven by Demand for Natural Ingredients
Ginger Extract Market to Reach USD 2.18 Billion by 2034 at 5.4% CAGR Driven by D …
The global ginger extract market is poised for substantial growth in the coming decade, with a projected valuation of USD 2.18 billion by 2034. According to the latest analysis from Market Research Future, the market was valued at USD 1.29 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2025 to 2034. This robust growth trajectory is largely fueled by increasing

All 5 Releases


More Releases for Mastitis

Bovine Mastitis Market Is Booming So Rapidly | Neogen, Vetoquinol, Dechra
The "Bovine Mastitis Market" intelligence report, just published by USD Analytics, covers a micro-level study of important market niches, product offers, and sales channels. To determine market size, potential, growth trends, and competitive environment, the Bovine Mastitis Market provides dynamic views. Both primary and secondary sources of data were used to generate the research, which has both qualitative and quantitative depth. Several of the major figures the study featured Zoetis,
Bovine Mastitis Market to Witness Stunning Growth | Elanco, Ceva, Virbac
A new business intelligence report released by USD Analytics with title "Global Bovine Mastitis Market Report 2030 " has abilities to raise as the most significant market worldwide as it has remained playing a remarkable role in establishing progressive impacts on the universal economy. The Global Bovine Mastitis Market Report offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary
Bovine Mastitis Market: Current Trends and Future Prospects
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. • CAGR: 6.3% • Current Market Size: USD 0.54 Billion • Forecast Growing Region: APAC • Largest Market: North America • Projection Time: 2021- 2031 • Base Year: 2021 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988 Bovine mastitis, an inflammatory condition of the mammary gland in dairy cows, poses
Global Bovine Mastitis Market: Prevalence, Challenges, and Opportunities
The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022 to 2031. • CAGR: 6.3% • Current Market Size: USD 0.54 Billion • Forecast Growing Region: APAC • Largest Market: North America • Projection Time: 2021- 2031 • Base Year: 2021 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 : https://www.alliedmarketresearch.com/request-sample/17988 Bovine mastitis is a prevalent and economically significant disease affecting dairy cattle worldwide.
Emerging Therapies and Innovations in the Bovine Mastitis Market
Bovine mastitis, a common and costly disease affecting dairy cattle, continues to be a significant challenge for the dairy industry worldwide. It is characterized by inflammation of the udder tissue, leading to reduced milk production, decreased milk quality, and increased treatment costs. The bovine mastitis market was valued at $0.54 billion in 2021 and is estimated to reach $1.01 billion by 2031, growing at a CAGR of 6.3% from 2022
Demand for Safe and Quality Milk Boosts Bovine Mastitis Market
Bovine mastitis is a common and serious disease that affects dairy cows. It is an inflammatory response of the udder tissue, caused by bacteria or other pathogens that infect the cow's mammary gland. Mastitis can cause milk production to decrease, and the milk produced can be of poor quality and even unsafe for human consumption. 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐔𝐩𝐝𝐚𝐭𝐞𝐝 𝐕𝐞𝐫𝐬𝐢𝐨𝐧 2023: https://www.alliedmarketresearch.com/request-sample/17988 The bovine mastitis market was valued at